Filing Flows

Filing Flows › Longeveron (LGVN) › How it makes money

How Longeveron (LGVN) makes money

Longeveron (LGVN) made $287K of revenue in the second quarter 2026 (Q2 2026), -9% from a year earlier.

Drawing the Sankey…

Longeveron: revenue by line, Q1 2025 to Q1 2026Longeveron: revenue by line, Q1 2025 to Q1 2026Clinical Trial RevenueContract Manufacturin…Contract Manufacturin…Clinical Trial Revenue: $378K latest$378KContract Manufacturing Revenue: $20K latestContract Manufacturing Lease Revenue: $0 latestQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Clinical Trial Revenue went from 68% of revenue in Q1 2025 to 95% in Q1 2026, the largest shift in the mix.
Longeveron revenue by quarterLongeveron revenue by quarter$603KQ4 2024$381KQ1 2025$316KQ2 2025$137KQ3 2025$365KQ4 2025$398KQ1 2026$287KQ2 2026

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$287K100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$287K-9%
Q1 2026$398K+4%
Q4 2025$365K-40%
Q3 2025$137K-82%
Q2 2025$316K-32%
Q1 2025$381K-30%
Q4 2024$603K+857%

From Longeveron's 10-Q filed Aug 12, 2026 (on EDGAR).

Questions

How does Longeveron make money?

Longeveron (LGVN) made $287K of revenue in the second quarter 2026 (Q2 2026), -9% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.